About Trace Biosciences
Trace Biosciences is a private company based in Beaverton, Oregon, incorporated in 2021 in Delaware. It has reported $8,334,499 raised in one offering on Form D since August 2026. Its chief executive is Connor Barth.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 28, 2026 | Aug 12, 2026 | $8,334,499of $16.2M target | 19 | $438K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Trace Biosciences's Form D filed Aug 12, 2026.
